Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2009
08/20/2009WO2009101084A1 Method for reprogramming differentiated cells
08/20/2009WO2009079775A9 Composition for supporting heat shock protein function comprising glutamine
08/20/2009WO2009066922A3 Method of differentiating islet-neighboring cells into insulin- secreting cells
08/20/2009WO2009065001A3 Cardiac conduction system (ccs) progenitor cells and uses thereof
08/20/2009WO2009029937A3 Methods and assays for screening stem cells
08/20/2009WO2009007852A3 Multipotent/pluripotent cells and methods
08/20/2009WO2008137635A3 Method for collecting and storing biological materials
08/20/2009WO2008089094A9 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
08/20/2009WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same
08/20/2009US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof
08/20/2009US20090210958 Nucleic acid encoding n-methylputrescine oxidase and uses thereof
08/20/2009US20090210956 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure
08/20/2009US20090210955 Shrna and sirna expression in a living organism under control of a codon-optimized repressor gene
08/20/2009US20090210954 Genes
08/20/2009US20090210953 Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release
08/20/2009US20090209749 Plant centromere compositions
08/20/2009US20090209735 Affinity separation by partition enhancing material conjugated biomolecules in aqueous two-phase extraction system
08/20/2009US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same
08/20/2009US20090209633 Treatment of Pain With Resiniferatoxin and Related Analogs
08/20/2009US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue
08/20/2009US20090209628 MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS
08/20/2009US20090209626 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation
08/20/2009US20090209625 Modulation of chrebp expression
08/20/2009US20090209624 Compositions and their uses for gene therapy of bone conditions
08/20/2009US20090209621 Compositions and methods for decreasing microrna expression for the treatment of neoplasia
08/20/2009US20090209573 Compounds and compositions as hedgehog pathway modulators
08/20/2009US20090209560 Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3
08/20/2009US20090209554 Thiazoliums as transketolase inhibitors
08/20/2009US20090209535 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
08/20/2009US20090209520 2 -oxybenzamide derivatives as parp inhibitors
08/20/2009US20090209507 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies
08/20/2009US20090209478 Compositions and methods for inhibiting expression of the hamp gene
08/20/2009US20090209473 Componds and methods for pormoting angiogenesis
08/20/2009US20090209467 composition for treatment of a pathologic disorder having as an active ingredient a therapeutically-effective amount of at least one SV40 VP1 65 amino acid truncated mutant deleted in its carboxy terminal arm, designated VP1 Delta C; treatment of immune-related or neurodegenerative disorders
08/20/2009US20090209458 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
08/20/2009US20090209453 Glycoprotein Hormone Analogs
08/20/2009US20090209045 Screening assay
08/20/2009US20090209039 Method and apparatus for microfluidic injection
08/20/2009US20090209035 Cell or tissue cultivation apparatus and method of cultivation
08/20/2009US20090209034 Tumour rejection antigens
08/20/2009US20090209033 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
08/20/2009US20090209021 Variant Form of Urate Oxidase and Use Thereof
08/20/2009US20090209020 collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system
08/20/2009US20090209008 Thermus thermophilus nucleic acid polymerases
08/20/2009US20090209006 Taci-immunoglobulin fusion proteins
08/20/2009US20090209005 Chimeric dna polymerase
08/20/2009US20090209004 Human il-1 beta antagonists
08/20/2009US20090209002 Compositions and methods relating to cellular targeting
08/20/2009US20090208995 Pro-clotting enzyme, and method for detection of endotoxin or (1-3)-beta-d-glucan using the same
08/20/2009US20090208978 Panel Cell Used for Granulocyte Antibody Detection
08/20/2009US20090208977 Materials and methods for sperm sex selection
08/20/2009US20090208972 Cytotoxic protein and utlization thereof
08/20/2009US20090208969 Polynucleotides and Polypeptides Encoding Receptors
08/20/2009US20090208953 Neurofibromin pathway modulators
08/20/2009US20090208946 Rationale, Methods, and Assays for Identifying Human and Non-Human Primate Taste Specific Genes and Use Thereof in Taste Modulator and Therapeutic Screening Assays
08/20/2009US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition
08/20/2009US20090208934 Pecam-1 genotype
08/20/2009US20090208919 Particle matrix for storage of biomolecules
08/20/2009US20090208918 Methods and devices for ex-vivo maintenance of bone marrow, hematopoiesis and blood cell production
08/20/2009US20090208580 Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles
08/20/2009US20090208577 Inkjet Printing of Tissues and Cells
08/20/2009US20090208564 Compositions of asymmetric interfering RNA and uses thereof
08/20/2009US20090208548 Copolymer-stabilized emulsions
08/20/2009US20090208537 Anti-Neovasculature Preparations for Cancer
08/20/2009US20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4
08/20/2009US20090208528 Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications
08/20/2009US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine
08/20/2009US20090208518 Immunogenic peptides for the treatment of prostate and breast cancer
08/20/2009US20090208516 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
08/20/2009US20090208514 Method of diagnosing esophageal cancer
08/20/2009US20090208506 Antibodies against flagellin and uses thereof
08/20/2009US20090208504 Polypeptides involved in immune response
08/20/2009US20090208502 Apoptosis-inducing protein complexes and therapeutic use thereof
08/20/2009US20090208500 Method of producing antibodies with improved function
08/20/2009US20090208496 Humanized anti-cd4 antibody with immunosuppressive properties
08/20/2009US20090208489 Antibodies That Bind OV064 and Methods of Use Therefor
08/20/2009US20090208487 Prevention and treatment of synucleinopathic and amyloidogenic disease
08/20/2009US20090208483 Antibody selective for dr4 and uses thereof
08/20/2009US20090208477 Production of high mannose proteins in plant culture
08/20/2009US20090208475 Mina53 assays
08/20/2009US20090208473 Compositions and methods to modulate cell membrane resealing
08/20/2009US20090208471 Isolation and Use of Human Regulatory T Cells
08/20/2009US20090208467 P27 and p21 in gene therapies
08/20/2009US20090208463 Mesenchymal stem cells and uses therefor
08/20/2009US20090208462 Methods of Treatment
08/20/2009US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions
08/20/2009US20090208454 Modified interferon beta polypeptides and their uses
08/20/2009US20090208449 Heterocyclic antiviral compounds
08/20/2009US20090208447 Polypeptides
08/20/2009US20090208416 Monoclonal antibodies against nkg2a
08/20/2009US20090208410 Ed-b fibronectin as stratification marker for anti-tumor drugs
08/20/2009CA2715536A1 Cd4+ t-cells with cytolytic properties
08/20/2009CA2715354A1 Dominant earliness mutation and gene in sunflower (helianthus annuus)
08/20/2009CA2715288A1 Compositions and methods for implantation of adipose tissue and adipose tissue products
08/20/2009CA2715058A1 Reconstructed cornea and mucous membrane
08/20/2009CA2714657A1 Anti-adam-15 antibodies and utilization of the same
08/19/2009EP2090663A2 Method of preparing heart muscle cells and method of searching for remedy for heart diseases
08/19/2009EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses
08/19/2009EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
08/19/2009EP2090650A1 Grain incomplete filling gene (gif1) and uses thereof
1 ... 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 ... 1827